Response Biomedical Q1 FY14: net loss $1.5M

Key figures from this report

These are the numbers Response Biomedical reported for Q1 FY14, the quarter ended Mar 31, 2014, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income−$1.5MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Cash and cash equivalents$4.0MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
3. Cash from operations−$272KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR